ALBT Avalon GloboCare Corporation: Rasio nilai perusahaan marang pendapatan

The defensive profile of Avalon GloboCare (ALBT) medical services minimizes the impact of GDP, although inflation may constrain expansion. Business resilience is bolstered by the success of clinical trials and product commercialization. The company's current price-to-sales ratio visualizes this balance, where 30057.14 is recorded as the baseline value. Capitalization growth here relies on a scalable cloud IT platform that analyzes genetic data using AI.
ALBT (Avalon GloboCare Corporation): rincian analitis lan laporan miturut indikator

Investors are assessing the business resilience of Avalon GloboCare (ALBT) through the enterprise value-to-revenue ratio, which eliminates the impact of debt load on the final valuation. By analyzing the company's EV/Revenue multiple, one can determine the fairness of its market value relative to medical services outsourcing revenues and the business's dependence on external IT contractors.